99
Participants
Start Date
September 16, 2020
Primary Completion Date
December 22, 2021
Study Completion Date
January 21, 2022
Placebo
Matching placebo for BAY1817080, will be taken twice daily orally as tablet(s)
BAY1817080
BAY1817080 will be taken twice daily orally as tablet(s)
Emeritus Research, Botany
Tauranga Urology Research Limited, Tauranga
Emeritus Research, Camberwell
Centro Hospitalar Universitario do Porto, Porto
Medizinische Universität Innsbruck, Innsbruck
Canterbury Urology Research Trust, Christchurch
Medizinische Universität Graz, Graz
"Überörtliche Gemeinschaftspraxis Urologie Neandertal", Mettmann
Urologicum Duisburg - Praxis Walsum, Duisburg
KK Women's and Children's Hospital, Singapore
Afimed s.r.o, Benešov
Gynekologie Cheb s.r.o., Cheb
G-Centrum Olomouc s.r.o. Dr. Skrivanek, Olomouc
GynCare MUDr. Michael Svec s.r.o., Pilsen
Urocentrum Praha, s.r.o., Prague
Androgeos - private center of urology and andrology, Prague
Fakultní nemocnice Bulovka, Prague
Urologicum, Eisleben Lutherstadt
Praxis Hr. Dr. M. Markov, Halle
Medico Praktyka Lekarska, Krakow
NZOZ NOVITA, Specjalistyczne Gabinety Lekarskie S.C, Lublin
Centrum Urologiczne Sp. z o.o., Mysłowice
NZOZ Heureka, Piaseczno
Przychodnia Lekarska Eskulap, Skierniewice
CHULN - Hospital Santa Maria, Lisbon
CHUSJ - Hospital Sao Joao, Porto
Göteborgs Urologmottagning, Gothenburg
Urogyn, Solna
Lead Sponsor
Bayer
INDUSTRY